PharmNXT acquires DTR, brings European bioprocess engineering to India
This move enables PharmNXT to access technology solutions related to single-use systems
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Pfizer completes licensing agreement with 3SBio
The agreement allows Pfizer to manufacture and commercialise 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF…
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share
The issue is expected to raise ₹4,992.51 lakh, which will be utilised to strengthen the company’s balance sheet, support growth…
NATCO Pharma offers to acquire stake in South African Adcock Ingram Holdings
Adcock Ingram generated revenue of R9.6 billion ($ 536 million*) in the financial year June’24 and delivered a gross margin of…
Akums launches high-strength Paracetamol Oral Suspension 500mg/5ml
This novel oral suspension is an addition to the analgesic and antipyretic category by offering therapeutic adult dosing in a…
Cipla invests in iCaltech Innovations to strengthen respiratory play
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core…
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape
According to GlobalData, the 2024 approvals included significant milestones in the biosimilar sector, with the FDA granting…
Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital
Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData
Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…
Pulmonary arterial hypertension market to reach $9.3 bn in 7MM by 2034
GlobalData’s latest report reveals that the US market is the largest PAH market in the 7MM, accounting for 76.3 per cent of global…
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData
According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in…
The medication is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis…
Endometriosis market to grow to $2.5 bn across 7MM in 2034
GlobalData’s latest report reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction…
Funding declines in pharma as June sees 97% plunge
Total funding reached $7.2 million across 5 rounds, representing a 97.07 per cent decrease from May 2025
Parexel appoints two FDA luminaries, Dr Lola Fashoyin-Aje, and Dr Tala Fakhouri to its Consulting…
These strategic appointments will bolster the company’s regulatory expertise
EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData
GlobalData attributes this drop to price competition from local manufacturers and China’s ongoing anti-corruption crackdown on the…
Pharmexcil reports robust exports: $ 2,475.70 mn in May 2025, Cumulating to $ 4,961.71 mn for…
According to the reports, a 7.38 per cent expansion was observed compared to May 2024-25